Semaglutide was a medication that was initially developed to treat type 2 diabetes and was found to help with significant medical weight loss. This medication assists in weight loss by decreasing gastric emptying, regulating blood sugar levels and suppressing appetite. This is achieved by mimicking a hormone called glucagon-like peptide-1 (GLP-1) . Semaglutide has demonstrated significant weight loss in multiple studies.
The FDA has approved Semaglutide for chronic weight management in obese patients or patients who are overweight with at least one weight-related health condition. Type 2 diabetes or high blood pressure are the most common.
GLP-1 Agonist can be an effective weight loss medication when used in conjunction with a weight management program, including a reduced-calorie diet and increased physical activity.
Dietary modifications should be followed, including a balanced, reduced-calorie diet that consists of a variety of nutrient-dense foods, such as fruits, vegetables, whole grains, lean proteins, and healthy fats. In addition, avoidance of greasy, fried , or highly processed foods, is highly recommended. Physical activity is also a very important component to a lifelong change in order to produce and maintain health and weight loss. One should aim for at least 150 minutes of moderate-intensity aerobic exercise or 75 minutes of vigorous-intensity aerobic exercise per week, along with muscle-strengthening activities on two or more days per week. Behavioral changes should be developed to overcome emotional eating, manage stress, and improve sleep quality. Proper hydration should be maintained by increasing water intake as needed, likely a minimum of 64oz per day.
Over the past 20 years, Dr. Kimbrell has consistently honed his surgical skills and medical knowledge, always intertwining his work with his passion for fitness and wellness including weight loss. He is dedicated to continuous learning and staying at the forefront of medical advancements.
Learn More About: Dr. Brian Kimbrell
* All specials and promotions are subject to change without notice. Some offers may expire based upon availability of products. Please consult with one of our providers if you have any questions. Specials cannot be combined with others offers.
Dr. Melinda Lacerna is the founder and owner of LA Plastic Surgery, The Skin Plasma Center, LA Skin Med Spa, and Elite Aesthetic Surgery Center. She has positioned herself as a leading expert, notably authoring significant works such as the “Non-surgical Facial Rejuvenation and Skin Resurfacing” chapter in the 9th edition of Grabb and Smith’s Plastic Surgery.
© 2024 All Rights Reserved • 5301 4th Ave Cir E Bradenton, FL 34208 • September 16, 2024 3:07 pm
